相关实验视频

Updated: Jul 5, 2025

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

所有CDKN2A误解变体的功能性表征和与病原性模型的比较

Hirokazu Kimura¹, Kamel Lahouel^2,3, Cristian Tomasetti^2,3

¹Department of Pathology, the Johns Hopkins University School of Medicine; Baltimore, 21287, USA.

bioRxiv : the preprint server for biology

|January 18, 2024

概括

对CDKN2A变异的基因测试面临解释挑战. 一项新的功能测试发现17.7%的误解变体是有害的,有助于临床变体解释和评估in silico模型.

科学领域:

遗传学遗传学是一个
分子生物学分子生物学
生物信息学是一种生物信息学.

背景情况:

解释在临床试验中发现的遗传变异是一个重大挑战.
准确的变种分类对于患者的诊断和治疗至关重要.
CDKN2A基因在各种癌症中经常发生变化,因此对其变体的解释至关重要.

研究的目的:

为所有可能的CDKN2A误解变体开发高通量功能测试.
为了对这些变体的功能影响进行分类.
用这些功能分类来评估in silico预测模型的性能.

主要方法:

为CDKN2A开发高通量功能测试.
描述所有可能的CDKN2A误解变体.
对功能分类的 in silico 变体预测模型的评估.

主要成果:

发现所有表征的CDKN2A误解变体中有17.7%是功能有害的.
包括基于机器学习的in silico模型,与功能分类相比,表现相似,准确度在39.5%至85.4%之间.
功能有害的变体在ankyrin重复中得到了丰富,但没有发现任何一个残留物,所有错误的变体都是有害的.

结论:

开发的功能分类为在临床环境中解释CDKN2A变异提供了宝贵的资源.
这些发现对应用变体解释指南有重大影响,特别是关于使用in silico工具.
这项研究强调了需要强大的功能数据来补充临床遗传学的计算预测.

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

In Vivo Modeling of the Morbid Human Genome using Danio rerio

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

相关概念视频

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

M-Cdk Drives Transition Into Mitosis

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...